Martin Gilligan

Martin Gilligan is the former Corporate Vice President in the Inflammation and Immunology Franchise at Celgene Corporation, where he led marketing, market access and business development. He held key leadership roles in the launch and growth of OTEZLA® through its sale to Amgen for $13.4B. Prior to joining Celgene, Mr. Gilligan has held both global and US sales and marketing roles, spanning 25 years in the biopharmaceutical industry. Mr. Gilligan holds a bachelor’s degree from Providence College and an M.B.A. from Rutgers University.